Publication:
Canakinumab treatment in adult-onset still's disease: Case series

dc.contributor.authorUğurlu, Serdal
dc.contributor.authorGüzelant, Gül
dc.contributor.authorYurttaş, Berna
dc.contributor.authorErgezen, Bilgesu
dc.contributor.authorDalkılıç, Ediz
dc.contributor.authorKaşifoğlu, Timuçin
dc.contributor.authorYağız, Burcu
dc.contributor.authorÖzdoğan, Huri
dc.contributor.buuauthorDALKILIÇ, HÜSEYİN EDİZ
dc.contributor.buuauthorYAĞIZ, BURCU
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentDahiliye Bölümü
dc.contributor.researcheridCMF-4757-2022
dc.contributor.researcheridJQW-5031-2023
dc.date.accessioned2024-07-26T05:49:14Z
dc.date.available2024-07-26T05:49:14Z
dc.date.issued2018-09-01
dc.descriptionBu çalışma, 19-24, Ocak 2018 tarihlerinde Chicago[Amerika]’da düzenlenen Annual Meeting of the American-College-of-Rheumatology (ACR) and Association-for-Rheumatology-Health-Professionals (ARHP) Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipAmer Coll Rheumatol
dc.description.sponsorshipAssoc Rheumatol Hlth Profess
dc.identifier.eissn2326-5205
dc.identifier.issn2326-5191
dc.identifier.urihttps://hdl.handle.net/11452/43457
dc.identifier.volume70
dc.identifier.wos000447268902424
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherWiley
dc.relation.journalArthritis & Rheumatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectRheumatology
dc.titleCanakinumab treatment in adult-onset still's disease: Case series
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Dahiliye Bölümü
relation.isAuthorOfPublication1613225c-2f43-4052-9f82-210c854edcf4
relation.isAuthorOfPublication02b3cfbb-e8e7-4a95-b025-294888ae9a91
relation.isAuthorOfPublication.latestForDiscovery1613225c-2f43-4052-9f82-210c854edcf4

Files

Collections